FDA removes black-box warnings from three more menopause patches

The US Food and Drug Administration said three more estrogen patches for menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer and dementia. The agency did not convene an advisory committee and gave few details on the evidence. Some experts criticised the lack of transparency, while officials pointed to shortages of menopause hormone treatments that patients are facing.